Skip to main content

Metabolic Reprogramming in Breast Cancer: A New Frontier in Therapy

  • 1st Edition, Volume 408 - April 1, 2027
  • Latest edition
  • Editors: Lorenzo Galluzzi, Jonathan POL, Esmeralda García Torralba, Isabelle Martins
  • Language: English

Metabolic Reprogramming in Breast Cancer: A New Frontier in Therapy explores how altered metabolic pathways drive breast cancer progression, survival, and treatment resist… Read more

End of Summer Sale

Save up to 30% off

Bright savings for research, study, and discovery

Description

Metabolic Reprogramming in Breast Cancer: A New Frontier in Therapy explores how altered metabolic pathways drive breast cancer progression, survival, and treatment resistance. The book highlights emerging insights into tumor metabolism and discusses how these discoveries may open new avenues for targeted and more effective therapies.

Key features

  • Provides the latest information on cancer research
  • Offers outstanding and original reviews on a range of cancer research topics
  • Serves as an indispensable reference for researchers and students alike

Readership

Academic libraries, university libraries, biomedical research institutes, life science researchers, cell biologists, molecular biologists

Table of contents

1. Metabolic alterations in breast cancer subtypes
Leire Arrizabalaga, Aitziber Buqué and Esmeralda García-Torralba

2. The tumor microenvironment and metabolic crosstalk in breast cancer
Ayoub Jaa

3. Therapeutic targeting of cancer metabolism
María Antonia Meroño Saura Sr., Miguel Almanchel Rivadeneyra, Noel Blaya Boluda and Esmeralda Garcia Torralba

4. Metabolic plasticity and drug resistance in breast cancer
ALICIA DE LUNA AGUILAR, ANDREA GOTTLOB PEREZ, DANIEL MONTERO MORENETE and JAVIER BENITEZ FUENTES

5. Metabolomics and biomarkers in breast cancer
Ana Fernández Sánchez

6. Influence of diet and lifestyle on breast cancer metabolism
Beatriz Navarro Santana, Patricia Escamilla, Esperanza Guirao Garcia, Sara Forte, Octavio ARENCIBIA, Manuel Cazorla, DANIEL GONZALEZ, Elizabeth Reyes, Fabio Francesco Ciancio and Alicia Martin Martinez

7. Future perspectives in metabolic therapy for breast cancer
Encarnación Pérez Cano

Product details

  • Edition: 1
  • Latest edition
  • Volume: 408
  • Published: April 1, 2027
  • Language: English

About the editors

LG

Lorenzo Galluzzi

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA

ET

Esmeralda García Torralba

Affiliations and expertise
1 Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. 2Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain. 3Department of Medicine, Medical School, University of Murcia, Murcia, Spain. 4IMIB-Arrixaca, Murcia, Spain.